THE RISK OF OSTEONECROSIS OF THE JAW IN TAIWANESE OSTEOPOROTIC PATIENTS TREATED WITH ORAL ALENDRONATE OR RALOXIFENE

被引：0
|
作者：
Chiu, W. -Y. [1 ]
Chien, J. -Y. [2 ]
Yang, W. -S. [3 ]
Juang, J. -M J. [2 ]
Lee, J. -J. [4 ]
Tsai, K. -S. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan
来源：
OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P695
引用
收藏
页码：S430 / S431
页数：2
相关论文
共 50 条
  • [1] The Risk of Osteonecrosis of the Jaws in Taiwanese Osteoporotic Patients Treated With Oral Alendronate or Raloxifene
    Chiu, Wei-Yih
    Chien, Jung-Yien
    Yang, Wei-Shiung
    Juang, Jyh-Ming Jimmy
    Lee, Jang-Jaer
    Tsai, Keh-Sung
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (08): : 2729 - 2735
  • [2] SURGICALLY TREATED OSTEONECROSIS AND OSTEOMYELITIS OF THE JAW AND ORAL CAVITY IN PATIENTS HIGHLY ADHERENT TO ALENDRONATE TREATMENT
    Abrahamsen, Bo
    Eiken, Pia
    Prieto-Alhambra, Daniel
    Eastell, Richard
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : 618 - 618
  • [3] Alendronate Use and the Risk of Osteonecrosis of Jaw in Taiwan
    Huang, Weng-Foung
    Lu, Pei-Yu
    Hsieh, Chi-Feng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 412 - 412
  • [4] ALENDRONATE USE AND THE RISK OF OSTEONECROSIS OF JAW IN TAIWAN
    Huang, W. F.
    Lu, P. Y.
    Hsieh, C. F.
    VALUE IN HEALTH, 2012, 15 (07) : A671 - A671
  • [5] Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
    Neuprez, A.
    Coste, S.
    Rompen, E.
    Crielaard, J. M.
    Reginster, J. Y.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (01) : 393 - 395
  • [6] Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
    A. Neuprez
    S. Coste
    E. Rompen
    J. M. Crielaard
    J. Y. Reginster
    Osteoporosis International, 2014, 25 : 393 - 395
  • [7] Medication-related osteonecrosis of the jaw, a risk to reassess in osteoporotic patients
    Somay, Efsun
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2023, 124 (06)
  • [8] The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects
    Chiu, Wei-Yih
    Yang, Wei-Shiung
    Chien, Jung Yien
    Lee, Jang-Jaer
    Tsai, Keh-Sung
    PLOS ONE, 2018, 13 (04):
  • [9] Medication-related osteonecrosis of the jaw, a risk to reassess in osteoporotic patients
    Debieve, M.
    Castiaux, L.
    van Maanen, A.
    Magremanne, M.
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2023, 124 (01)
  • [10] Osteonecrosis of the jaw secondary to oral alendronate. Report of three cases
    Bocanegra-Perez, Sacramento
    Vicente-Barrero, Mario
    Sosa-Henriquez, Manuel
    Gebaguer Blanco, Arwen
    Knezevic, Milan
    Maria Castellano-Navarro, Jose
    REVISTA MEDICA DE CHILE, 2009, 137 (02) : 275 - 279
12345